- Home
- BQ vs ADTX Comparison
BQ vs ADTX Comparison
Compare BQ & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- ADTX
- Stock Information
- Founded
- BQ 2008
- ADTX 2017
- Country
- BQ China
- ADTX United States
- Employees
- BQ N/A
- ADTX N/A
- Industry
- BQ Other Specialty Stores
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- ADTX Health Care
- Exchange
- BQ Nasdaq
- ADTX Nasdaq
- Market Cap
- BQ 5.7M
- ADTX 5.3M
- IPO Year
- BQ 2020
- ADTX 2020
- Fundamental
- Price
- BQ $0.32
- ADTX $0.24
- Analyst Decision
- BQ
- ADTX
- Analyst Count
- BQ 0
- ADTX 0
- Target Price
- BQ N/A
- ADTX N/A
- AVG Volume (30 Days)
- BQ 193.0K
- ADTX 1.1M
- Earning Date
- BQ 12-31-2024
- ADTX 11-18-2024
- Dividend Yield
- BQ N/A
- ADTX N/A
- EPS Growth
- BQ N/A
- ADTX N/A
- EPS
- BQ N/A
- ADTX N/A
- Revenue
- BQ $98,241,396.00
- ADTX $212,107.00
- Revenue This Year
- BQ N/A
- ADTX $95.61
- Revenue Next Year
- BQ N/A
- ADTX $1,584.79
- P/E Ratio
- BQ N/A
- ADTX N/A
- Revenue Growth
- BQ N/A
- ADTX N/A
- 52 Week Low
- BQ $0.22
- ADTX $0.24
- 52 Week High
- BQ $0.74
- ADTX $338.80
- Technical
- Relative Strength Index (RSI)
- BQ 33.12
- ADTX 18.34
- Support Level
- BQ $0.32
- ADTX $0.25
- Resistance Level
- BQ $0.38
- ADTX $0.39
- Average True Range (ATR)
- BQ 0.03
- ADTX 0.03
- MACD
- BQ -0.01
- ADTX 0.12
- Stochastic Oscillator
- BQ 4.48
- ADTX 11.83
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.